Cite
Supplementary Figures 1-3, Tables 1-3 from A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303
MLA
Mark J. Ratain, et al. Supplementary Figures 1-3, Tables 1-3 from A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2bd7a0bf31a75d38f507299f7efbc59b&authtype=sso&custid=ns315887.
APA
Mark J. Ratain, Yusuke Nakamura, Hedy L. Kindler, Richard L. Schilsky, Richard M. Goldberg, Howard L. McLeod, Kathleen M. Giacomini, Herbert Hurwitz, Dylan Glubb, Liewei Wang, Paula Friedman, Liang Li, Taisei Mushiroda, Donna Hollis, Chen Jiang, Hitoshi Zembutsu, Michiaki Kubo, Patrick Evans, Nancy L. Cox, … Federico Innocenti. (2023). Supplementary Figures 1-3, Tables 1-3 from A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303.
Chicago
Mark J. Ratain, Yusuke Nakamura, Hedy L. Kindler, Richard L. Schilsky, Richard M. Goldberg, Howard L. McLeod, Kathleen M. Giacomini, et al. 2023. “Supplementary Figures 1-3, Tables 1-3 from A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2bd7a0bf31a75d38f507299f7efbc59b&authtype=sso&custid=ns315887.